• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

验证数据展示

  • WB analysis using 31403-1-AP

    WB analysis using 31403-1-AP

    Various lysates were subjected to SDS PAGE followed by western blot with 31403-1-AP (P62,SQSTM1 antibody) at dilution of 1:3000 incubated at room temperature for 1.5 hours.

  • WB analysis using 31403-1-AP

    WB analysis using 31403-1-AP

    Various lysates were subjected to SDS PAGE followed by western blot with 31403-1-AP (P62,SQSTM1 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

  • IP experiment of NIH/3T3 using 31403-1-AP

    IP experiment of NIH/3T3 using 31403-1-AP

    IP result of anti-P62,SQSTM1 (IP:31403-1-AP, 4ug; Detection:31403-1-AP 1:5000) with NIH/3T3 cells lysate 1920 ug.

  • IF Staining of HepG2 using 31403-1-AP

    IF Staining of HepG2 using 31403-1-AP

    Immunofluorescent analysis of (-20°C Ethanol) fixed Chloroquine treated HepG2 cells using P62,SQSTM1 antibody (31403-1-AP) at dilution of 1:200 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2), CL594-phalloidin (red).

P62/SQSTM1 Polyclonal antibody

P62/SQSTM1 Polyclonal Antibody for WB, IF/ICC, IP, ELISA
Cat No. 31403-1-AP

产品说明书

引用文献(1)

宿主/亚型

Rabbit / IgG

种属反应性

human, mouse

应用

WB, IF/ICC, IP, ELISA

别名

P62,SQSTM1, p62, Sqstm1, OSF 6, Osi

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -

点击咨询售前客服

点击咨询售后客服

经过测试的应用

Positive WB detected inNIH/3T3 cells, mouse brain tissue, RAW 264.7 cells
Positive IP detected inNIH/3T3 cells
Positive IF/ICC detected inChloroquine treated HepG2 cells

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:1000-1:6000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

发表文章中的应用

WBSee 1 publications below

产品信息

31403-1-AP targets P62/SQSTM1 in WB, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse samples.

经测试应用 WB, IF/ICC, IP, ELISA Application Description
文献引用应用WB
经测试反应性 human, mouse
文献引用反应性human
免疫原 P62/SQSTM1 fusion protein Ag35064 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 sequestosome 1
别名 P62,SQSTM1, p62, Sqstm1, OSF 6, Osi
计算分子量48 kDa
观测分子量 62 kDa
GenBank蛋白编号NM_011018
基因名称 P62/SQSTM1
Gene ID (NCBI) 18412
RRIDAB_3669966
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity Purification
UNIPROT IDQ64337
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Sequestosome 1 (SQSTM1/p62) is a multifunctional adaptor protein implicated in selective autophagy, cell signaling pathways, and tumorigenesis. p62 has been implicated in shuttling ubiquitinated and aggregated proteins for autophagic degradation. p62 is degraded during the autophagic process, which makes its intracellular level a marker for autophagy progression. p62 is at the cross-roads of several signaling pathways including Ras/ Raf/ MAPK and NFκB and plays important role in cancer.

实验方案

Product Specific Protocols
WB protocol for P62/SQSTM1 antibody 31403-1-APDownload protocol
IF protocol for P62/SQSTM1 antibody 31403-1-APDownload protocol
IP protocol for P62/SQSTM1 antibody 31403-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanWB

Int J Colorectal Dis

AQP3 mediates autophagy through SIRT1/p62 signal to alleviate intestinal epithelial cell damage caused by sepsis

Authors - Canmin Wang
View Article